Chemoradiotherapy with and without deep regional hyperthermia for squamous cell carcinoma of the anus
ConclusionAdditional regional hyperthermia improved overall survival, local control, and colostomy rates. Its potential beneficial role has to be confirmed in a prospective randomized setting. Therefore, the HyCAN trial has already been established by our group and is currently recruiting patients (Clinicaltrials.gov identifier: NCT02369939).
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Anal Cancer | Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | Skin Cancer | Squamous Cell Carcinoma | Toxicology